Several major players in the global race for a coronavirus vaccine took steps to move their research forward this week.
Pharmaceutical companies developing potential vaccines, including Moderna and Johnson & Johnson, announced start times for various phases of clinical trials in humans. In addition, a U.S. Army lab announced the selection of a lead vaccine candidate, along with two backups that they plan to pursue.
Full NBC News coverage of the coronavirus outbreak
While most researchers are looking forward to new therapeutics, others are considering old vaccines to provide a temporary boost.
Click here for a roundup of the most notable vaccine news of the week.
